EQJ-31680-88678
4 vaccinations
9 coded responses
29 check-ins
8 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 453 / OH
- Registered
- 2020-12-30
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-30
Registered in v-safe
-
2020-12-30
Dose 1 — Moderna
- 2020-12-30
-
2020-12-31
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain, Redness · Headache, Fatigue or tirednessAdult check-in
-
2021-01-01
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-01-02
-
2021-01-03
Survey response — days 1–6 daily, dose 1MedDRA: Vertigo — Feeling: Fair · Headache, Fatigue or tirednessFree text: VertigoMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-04
Health check-in — days 1–6 daily, dose 1Feeling: Good · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-01-08
-
2021-01-20
Survey response — day 21, dose 1MedDRA: Migraine — Feeling: Fair · Be unable to work, Be unable to do your normal daily activitiesFree text: MigraineMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-26
Dose 2 — Moderna
-
2021-01-27
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain, Redness, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-01-28
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain, Redness, Swelling · Fever · Headache, Fatigue or tiredness, Diarrhea · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-29
Survey response — days 1–6 daily, dose 2MedDRA: Cough, Rhinorrhoea — Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Chills, Headache, DiarrheaFree text: Rhinorrhea, coughMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-30
Survey response — days 1–6 daily, dose 2MedDRA: Cough, Nasal congestion — Feeling: Fair · Site: Pain, Redness, Swelling · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Cough, nasal congestionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-31
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Redness, Swelling · Headache, Fatigue or tirednessAdult check-in
-
2021-02-01
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Redness · Headache, DiarrheaAdult check-in
-
2021-02-02
Survey response — day 7, dose 2MedDRA: Pain in extremity — Feeling: Good · Site: RednessFree text: Pain down arm below injection siteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-09
- 2021-02-16
- 2021-02-23
- 2021-03-02
- 2021-03-09
-
2021-04-27
Survey response — 3 months, dose 2MedDRA: Abortion spontaneous, Pregnancy — Feeling: Poor · Be unable to work, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Pregnancy and miscarriageMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-27
Report sent to call center — 3 months, dose 2Be unable to work · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-05-18
- 2021-07-27
-
2021-12-19
Dose 3 — Moderna
-
2022-01-29
Survey response — 12 months, dose 2MedDRA: Sleep apnoea syndrome, Undifferentiated connective tissue disease — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Sleep apnea, undifferentiated connective tissue diseaseMedDRA releases: 2024-11 · check-in free text available
-
2022-01-29
Report sent to call center — 12 months, dose 2Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-02-01
-
2022-09-27
Dose 4 — Pfizer-BioNTech
-
2022-10-21
Survey response — day 21, dose 4MedDRA: Asthma, Pre-existing disease, Upper respiratory tract infection — Feeling: Fair · Be unable to work or attend schoolFree text: URI and asthma exacerbationMedDRA releases: 2024-11 · check-in free text available
- 2022-10-25
- 2022-11-01
- 2022-11-08
- 2022-12-27
-
2023-03-28
Survey response — 6 months, dose 4MedDRA: Preterm premature rupture of membranes — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, HospitalizationMedDRA releases: 2024-11
-
2023-03-28
Report sent to call center — 6 months, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · Hospitalization · 1 call case(s)
-
2023-03-29
Call successfulDoes not wish to fill out VAERS report
-
2023-03-29
Call successfulDoes not wish to fill out VAERS report
-
2023-03-29
Call successfulDoes not wish to fill out VAERS report
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-30 | Moderna | |
| 2 | 2021-01-26 | Moderna | |
| 3 | 2021-12-19 | Moderna | No |
| 4 | 2022-09-27 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-04-27 | Successful 2023-03-29 |
Does not wish to fill out VAERS report |
| 2022-01-29 | Successful 2023-03-29 |
Does not wish to fill out VAERS report |
| 2023-03-28 | Successful 2023-03-29 |
Does not wish to fill out VAERS report |
Free text
Release 1 — days 1–6 daily, dose 1
Systemic reaction (other): Vertigo
Release 2 — day 21, dose 1
Symptoms: Migraine
Release 3 — days 1–6 daily, dose 2
Systemic reaction (other): Rhinorrhea, cough
Systemic reaction (other): Cough, nasal congestion
Release 3 — day 7, dose 2
Systemic reaction (other): Pain down arm below injection site
Release 8 — 3 months, dose 2
Symptoms: Pregnancy and miscarriage
Release 11 — 12 months, dose 2
Symptoms: Sleep apnea, undifferentiated connective tissue disease
Release 12 — day 21, dose 4
Symptoms: URI and asthma exacerbation
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Abortion spontaneous | ✓ | ✓ | ✓ |
| SD | Asthma | · | · | ✓ |
| SD | Migraine | ✓ | ✓ | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Pregnancy | ✓ | ✓ | ✓ |
| SD | Preterm premature rupture of membranes | · | · | ✓ |
| SD | Sleep apnoea syndrome | · | · | ✓ |
| SD | Undifferentiated connective tissue disease | · | · | ✓ |
| SD | Upper respiratory tract infection | · | · | ✓ |
| SRO | Cough | ✓ | ✓ | ✓ |
| SRO | Nasal congestion | ✓ | ✓ | ✓ |
| SRO | Pain in extremity | ✓ | ✓ | ✓ |
| SRO | Rhinorrhoea | ✓ | ✓ | ✓ |
| SRO | Vertigo | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release